Medical tubing and formulations therefor

Medical tubing made from thermoplastic materials, fillers, and coupling agents addresses the limitations of PVC by providing kink resistance and improved resilience, ensuring effective fluid delivery and environmental safety.

JP2024545393APending Publication Date: 2024-12-06CAREFUSION 303 INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024525370
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-10-28
Filing Date
2022-10-26
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing medical tubing, particularly those made from plasticized polyvinyl chloride, suffer from issues such as stickiness, tube blockage, tearing, and contamination due to plasticizer migration, while alternative materials lack the necessary kink resistance and viscoelastic properties for infusion and pump applications.

Method used

The development of medical tubing composed of thermoplastic materials, non-silane-reactive fillers, and thermally-reactive coupling agents, which form a homogeneous polymer system, providing kink resistance and improved resilience without plasticizers or polyvinyl chloride, suitable for use in infusion sets and catheters.

Benefits of technology

The new tubing exhibits comparable kink resistance to PVC, maintains flow accuracy, reduces leachable components, and offers superior properties like solvent adhesion, sterility, and environmental friendliness, making it suitable for infusion pumps and IV administration.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024545393000001_ABST
    Figure 2024545393000001_ABST
Patent Text Reader

Abstract

The medical tubing has at least one layer having a composition prepared from a melt blend of (i) a thermoplastic material, (ii) a filler, and (iii) a thermally reactive coupling agent. The medical tubing can have a kink resistance comparable to that of medical tubing constructed of polyvinyl chloride having the same tube wall dimensions. The medical tubing can be multi-layered and can include single lumen and multi-lumen tubing.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to U.S. Provisional Application No. 63 / 273,019, filed October 28, 2021, the disclosure of which is incorporated by reference in its entirety herein.

[0002] The present disclosure relates generally to medical tubing, and more particularly to kink-resistant, flexible medical tubing that can be prepared from thermoplastic materials, fillers, and reactive coupling agents, preferably without polyvinyl chloride or plasticizers. Such tubing can be used in medical devices, such as tubing for administration of medical fluids by infusion, as tubing for expansion sets, catheters, and the like, including those having complex tubing configurations with multiple lumens. [Background technology]

[0003] Plastic tubing is widely used in the medical field, especially for patient analysis and treatment procedures. Such use requires that the tubing be flexible, easy to pinch, and quick to rebound. Soft tubing, such as polyvinyl chloride with plasticizers, has been used in infusion sets for many years. Unfortunately, plasticized polymeric materials, such as plasticized polyvinyl chloride, can be sticky, leading to blockage and tearing of the tubing. Furthermore, tubing made with plasticizers can migrate into and contaminate the fluid being transported through the tubing.

[0004] However, there continues to be a need to prepare medical tubing, such as for the delivery of medical fluids. Summary of the Invention

[0005] Aspects of the present technology relate to medical tubing, particularly to medical tubing for administering medical fluids by infusion, and for use as expansion sets and catheters. According to certain aspects, the medical tubing can include one or more layers having a composition prepared from a melt blend of (i) a thermoplastic material, (ii) a filler (e.g., an inorganic filler and / or a non-silane reactive filler), and a thermally reactive coupling agent. Other layers of the tubing can include an inner layer in contact with the medical fluid, e.g., a polyolefin such as polyethylene, and the melt blend composition forms an outer layer. Additionally, the medical tubing of the present disclosure can include single lumen tubing and tubing with two or more lumens, i.e., multi-lumen medical tubing.

[0006] Advantageously, the medical tubing or layers thereof of the present disclosure can be substantially plasticizer-free or polyvinyl chloride-free, yet still have kink resistance, hi some aspects, the medical tubing has kink resistance sufficient to perform in a pump and comparable to medical tubing constructed of polyvinyl chloride, preferably with the same wall dimensions.

[0007] The present technology also relates to an infusion set including a medical tube. The present technology also relates to preparing a melt blend of a composition that can be used to form a medical tube or a layer thereof. In one aspect, the medical tube can be prepared by combining a thermoplastic material, a non-silane reactive filler, and a heat-reactive coupling agent with sufficient heat to form a melt blend composition. The formed melt blend composition can be pelletized or extruded into a suitable form for storage or transportation, or the formed melt blend composition can be extruded directly or in a subsequent step into a medical tube.

[0008] Further advantages of the present technology will be readily apparent to those skilled in the art from the following detailed description, but only certain aspects of the present technology are shown and described for illustrative purposes only. As will be appreciated, the present technology is capable of other different configurations, and its several details are capable of modification in various other respects, all without departing from the present technology. Accordingly, the drawings and description should be regarded as illustrative in nature, and not as restrictive.

[0009] The accompanying drawings, which are included to provide a further understanding, and which are incorporated in and constitute a part of this specification, illustrate disclosed embodiments and, together with the description, serve to explain the principles of the disclosed embodiments. [Brief description of the drawings]

[0010] [Figure 1] 1 is a table of several formulations prepared by mixing a thermoplastic elastomer (SEBS / PP), a filler, and a coupling agent. The table also includes a control formulation.

[0011] [Diagram 2] 1 is a plot of the corrected kink results for a typical PVC tube.

[0012] [Diagram 3] 1 illustrates kink and dimensional data for compounded thermoplastic materials according to aspects of the present disclosure compared to thermoplastic materials without fillers and coupling agents. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0013] The detailed description described below describes various configurations of the present technology and is not intended to represent the only configurations in which the present technology can be implemented. The detailed description includes specific details for the purpose of providing a thorough understanding of the present technology. Thus, dimensions are given as non-limiting examples for certain embodiments. However, it will be apparent to those skilled in the art that the present technology can be implemented without these specific details. In some instances, well-known structures and components are shown in block diagram form to avoid obscuring the concepts of the present technology.

[0014] It should be understood that the present disclosure includes examples of the present technology and does not limit the scope of the appended claims. Various aspects of the present technology are disclosed below according to specific but non-limiting examples. The various embodiments described in the present disclosure can be implemented in various ways and modifications according to a desired application or implementation.

[0015] Aspects of the present technology relate to medical tubing, particularly medical tubing for administering medical fluids by infusion, and for use as single or multi-lumen extension tubes and catheters. According to certain aspects, the medical tubing can include at least one layer having a composition prepared from a melt blend of (i) a thermoplastic material, (ii) a non-silane reactive filler, and a thermally reactive coupling. Additionally, the medical tubing of the present disclosure can include single lumen tubing and tubing having two or more lumens, i.e., multi-lumen medical tubing. Advantageously, the medical tubing of the present disclosure has sufficient kink resistance for use with infusion pumps. Other layers of the tubing can include an inner layer in contact with the medical fluid, e.g., a polyolefin such as polyethylene, with the melt blend composition forming an outer layer. In some aspects, the medical tubing has kink resistance sufficient to perform with the pump and comparable to medical tubing preferably constructed of polyvinyl chloride with the same wall dimensions. In some embodiments, the medical tubing of the present disclosure can have a wall thickness ranging from about 0.0075 inches to about 0.03 inches, e.g., from about 0.01 to about 0.025 inches, and a kink resistance ranging from about 0.70 inches to about 1.1 inches, e.g., from about 0.89 inches to about 0.95 inches.

[0016] The inorganic fillers are believed to be linked to the thermoplastic polymer chains by thermally reactive coupling agents to form a generally homogeneous polymer system that acts like a cross-linked material. Such structures are expected to improve the resilience of the thermoplastic polymer material, enhancing its kink resistance and pumping power under repeated deformation.

[0017] Achieving the desired kink resistance and maintaining flow rate accuracy throughout a typical pumping period is difficult to achieve with any material. The material is expected to retain its elastic properties, kink resistance, etc. well throughout the cycles of pump use. Kink resistance also requires a good balance between the viscous and elastic properties of the polymer. PVC-free thermoplastic polyolefins (TPOs) or thermoplastic elastomers (TPEs) are more environmentally friendly than PVC in the sense that such thermoplastics often contain no plasticizers or, if they do, in significantly less amount than the typical PVC formulations required for tubing used in pump applications. As a result, leachable components from such thermoplastics can be minimized or eliminated. However, it has been difficult to match the viscoelastic properties of PVC or its tunability with alternative materials while still meeting other desirable properties of PVC tubing, such as solvent adhesion, sterilizability, etc.

[0018] Some advantages of the disclosed compositions for medical tubing compared to PVC include one or more of: relative cost comparability or less, environmentally friendly materials, reduced leachables, equal or better flow rates and precision when pumping, pump and clamp compatibility, equal or better kink resistance, excellent tear resistance and resistance to bulging under fluid pressure, excellent compression set and therefore rebound necessary for clamp compatibility, simpler processing steps and reduced cycle times, useful for light sensitive drug delivery applications due to the light blocking properties of the filler, and / or increased heat resistance.

[0019] According to certain embodiments, the tube for intravenous administration can include thermoplastic polymer materials that do not include polyvinyl chloride (PVC). Such thermoplastic polymer materials include, for example, thermoplastic olefins (TPOs), such as polypropylene, polyethylene, thermoplastic elastomers (TPEs), such as styrene-containing thermoplastic elastomers (S-TPEs), such as styrene block copolymers (SBCs), such as styrene-butadiene-styrene copolymers (SBS), styrene-butadiene-styrene-styrene block copolymers (SBSS), styrene-isoprene-styrene (SIS), polyolefin elastomers (POEs), or blends containing them. To improve thermo-oxidative and UV stability, the unsaturated rubber blocks of the S-TPE elastomers (e.g., the polybutadiene or polyisoprene rubber blocks of SBS, SBSS, or SIS polymers) can be hydrogenated to form hydrogenated styrenic thermoplastic elastomers, including, but not limited to, styrene-ethylene-butylene-styrene thermoplastic elastomers (SEBS), styrene-ethylene / propylene-styrene (SEPS). High performance thermoplastic elastomers (TPEs) have been designed as sustainable alternatives to flexible PVC for medical tubing and films. Additionally, tubing can include blends of hydrogenated styrenic thermoplastic elastomers with hydrogenated or saturated polyolefins such as polypropylene, e.g., homo, block, and / or random polypropylenes such as random copolymer polypropylene (RCPP).

[0020] The thermoplastic material can be included as part of the tubing composition or in the layer composition in an amount of at least about 1% by weight to about 99% by weight, based on the total weight of the medical tubing composition or the total weight of the tubing layer compositions.

[0021] Useful fillers that can be included in the medical tubing or layers thereof include inorganic fillers and / or non-silane reactive fillers such as silica, glass beads, metal carbonates such as calcium carbonate, metal oxides, carbon black, mica, nepheline syenite, and the like. Such fillers can interact with a heat-reactive coupling agent. The heat-reactive coupling agent chemically crosslinks the non-silane reactive fillers such as CaCO3, carbon black and silica, metal oxides, and the like with the polymer. More specifically, white mica, nepheline syenite, calcium carbonate, and glass beads can also be used as fillers in the present formulation. As an example, mica and glass beads having particle sizes ranging from about 5 to about 26 micrometers can be used. The fillers can be included as part of the tube composition or in the layer composition in an amount of at least about 0.1% to about 20% by weight, based on the total weight of the medical tubing composition or the total weight of the tubing layer composition. For example, the composition may contain about 0.1% or more, e.g., at least about 0.5%, 0.75%, 1% by weight, but not more than about 20% by weight, e.g., about 15%, 10%, 5%, 3%, 2% by weight, or less, e.g., from about 1% to about 10% by weight, of the total composition, of filler.

[0022] Thermally reactive coupling agents that may be used with the medical tubing of the present disclosure include neopentyl(diallyl)oxy, tri(dioctyl)phosphato zirconate, neopentyl(diallyl)oxy, tri(dioctyl)phosphate titanate (available from Kenrich Petrochemicals, Inc.), KA® 301 di-isobutyl(oleyl)acetoacetylaluminate, KA 322 di-isopropyl(oleyl)acetoacetylaluminate, KR® OPPR titanium IV bisoctanolate, cyclo(dioctyl)pyrophosphato-O,O, KR OPP2 titanium IV biscyclo(dioctyl)pyrophosphato-O,O, KZ® TPP zirconium IV 2-ethyl,2-propenolatomethyl Examples of suitable thermally reactive coupling agents include 1,3-propanediolate, cyclodi 2,2-(bis 2-propenolatomethyl)butanolate pyrophosphate-O,O, KZ® OPPR zirconium IV bis 2-ethylhexanolate, cyclo(di 2-ethylhexyl) pyrophosphate, isopropyl triisostearoyl titanate, and the like. Such thermally reactive coupling agents can improve toughness, elongation, and flow of polymers at low temperatures, thus resulting in faster extrusion, blow molding, and injection molding cycle times, and higher quality parts, as measured by appearance, chemical resistance, and impact resistance. In contrast, organosilanes do not function as binders, as little or no surface interaction with calcium carbonate, barium, and boron, and the like, has been reported. In contrast, thermally reactive coupling agents, such as those disclosed herein, are more reactive than silanes. In addition, silanes react with water and are therefore difficult to handle in moist environments and to quality control through storage.

[0023] The thermally reactive coupling agent can be included as part of the tubing composition or in the layer composition in an amount of at least about 0.5% to about 20% by weight of the total medical tubing composition or the composition of a layer of the tubing. For example, the tubing composition can include more than about 0.5% by weight, e.g., at least about 0.75% by weight, 1% by weight, but not more than about 20% by weight, e.g., about 15% by weight, 10% by weight, 5% by weight, 3% by weight, 2% by weight, or less, e.g., about 1% by weight to about 10% by weight of the coupling agent of the total medical tubing composition or the composition of a layer of the tubing.

[0024] Fillers and thermally reactive coupling agents can be adjusted to balance material stiffness, processability, transparency and performance. As the filler concentration increases in the tube composition or in its layers, the composition tends to lose transparency and take on the color of one or more particular fillers.

[0025] The medical tubing of the present disclosure may include additives in one or more layers thereof, such as colorants, UV blockers, radiopaque stripes, among other additives. Such additives may be present in the main layer or in the outer layer of the tubing.

[0026] In certain aspects of the technology, the medical tubing of the present disclosure can be substantially free of plasticizers or free of polyvinyl chloride, yet still be kink resistant. By the medical tubing or a layer thereof being substantially free of PVC, it is meant that PVC is less than about 0.1% by weight of the layer or tubing composition.

[0027] A plasticizer is an additive that increases the plasticity or reduces the viscosity of a material, such as a polymeric material. As used herein, a plasticizer is an additive that can be included in a polymeric material to increase the flexibility of the polymeric material and reduce harnessing. Such plasticizers include, but are not limited to, low molecular weight esters, such as aliphatic and aromatic esters, citrates, dibenzoates, gluterates, azelates, terephthalates, and trialkyl trimellitates. Examples of the aliphatic esters include sebacic acid esters, adipic acid esters such as di(2-ethylhexyl) adipate (DEHA), di(2-ethylhexyl) azelaate (DOZ), di(2-ethylhexyl) sebacate (DOS), citrate esters such as acetyl tri-n-butyl citrate (ATBC) and n-butyryl-tri-n-hexyl citrate (BTHC), acetyl tri-n-hexyl citrate (ATHC), and 1,2-cyclohexanedicarboxylic acid diisononyl ester (DINCH). Examples of the aromatic esters include terephthalic acid esters, e.g. For example, di(2-ethylhexyl) terephthalate (DEHT), phthalate esters such as di(2-ethylhexyl) phthalate (DEHP), diisononyl phthalate (DINP), bis(2-propylheptyl) phthalate (DPHP), diisodecyl phthalate (DIDP), tri-2-ethylhexyl trimellitate (TOTM). Such plasticizers are preferably substantially, if not completely, excluded from the medical tubing or layers thereof of the present disclosure. By substantially excluded from the medical tubing or layers thereof, it is meant that they are less than about 0.1% by weight of the layer or tubing composition.

[0028] The medical tubing of the present disclosure can have good solvent adhesion, an indication of such adhesion being that the tubing swells in a given solvent that can be used to solvent bond the tubing to components or other tubing.

[0029] The tubing of the present disclosure is particularly useful in conjunction with an intravenous assembly, gravity-fed container, and / or infusion pump for delivering intravenous fluids to a patient. The assembly of tubing, valves, fittings, and needles that connects a fluid container to a patient intravenously may also be referred to as an "IV set."

[0030] An infusion pump is a medical device that can be used to administer intravenous (IV) fluids. Infusion pumps can facilitate the delivery of IV fluids while controlling the volume and rate of delivery of such IV fluids. Some infusion pumps use a peristaltic pumping mechanism that compresses and releases flexible tubing to force fluid movement within the tubing to move fluids within the tubing. For use in applications involving IV sets and / or infusion pumps, the tubing of the present disclosure can have an inner diameter for fluid flow ranging from about 1.5 mm to about 6 mm, e.g., from about 2 mm to 4 mm, and an overall sidewall thickness ranging from 0.2 mm to 0.8 mm, e.g., from 0.4 mm to 0.6 mm.

[0031] The present technology also relates to preparing melt blends of compositions that can be used to form medical tubing or layers thereof. In one aspect, medical tubing can be prepared by combining (i) a thermoplastic material, (ii) a non-silane reactive filler, and (iii) a thermally reactive coupling agent with sufficient heat to form a melt blend composition. Such melt blend compositions can be prepared by an extruder, for example a twin screw extruder. The formed melt blend composition can be directly extruded into medical tubing. Alternatively, the formed melt blend composition can be pelletized or extruded into a suitable form for storage or transportation. The extruded pellets or other form can then be extruded into medical tubing.

[0032] For example, a thermoplastic polymeric material, a filler, and a thermally reactive coupling agent can be mixed in a twin screw extruder to form a compounded tubing composition which can then be directly extruded into a tube or pelletized and then processed into a tube in a single screw extruder, or the like. example

[0033] The following examples are intended to further illustrate certain preferred embodiments of the invention and are not limiting in nature. Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, numerous equivalents to the specific substances and procedures described herein.

[0034] Several formulations were prepared by mixing the following components: thermoplastic elastomer (SEBS / PP), filler, and coupling agent. The thermoplastic materials with filler and coupling agent, for example, formulations are shown in the table in FIG. 1. The table also includes a control formulation. The formulations were then melt blended into pellet form by compounding in a twin screw extruder, and the pellets were subsequently extruded by a single screw extruder into medical tubing with an outer diameter of about 0.145 inches and an inner diameter of about 0.107 inches. The extruded medical tubing was then tested with solvents to determine their swelling properties. Swelling studies showed that the extruded tubing swelled in dibromomethane, cyclohexanone, and ethylene dichloride. Swelling in solvents suitable for medical devices is desirable for solvent bonding compatibility. Materials that do not swell require alternative bonding techniques.

[0035] Additionally, the swelling of the filled extruded tubing formulations was increased compared to the unfilled control, suggesting increased solvent diffusion into the thermoplastic material and potentially increased solvent adhesion of the material. The increased swelling of the filled extruded tubing formulations compared to the unfilled control was unexpected.

[0036] This was unexpected since the fillers were not expected to increase adhesion or interaction with the selected organic solvents. Fillers are known to be inert and chemically resistant. For example, calcium carbonate (CaCO3) can be dissolved with strong acids, and mica, like all silicates, can be slowly dissolved by hot concentrated alkali. Apart from that, such fillers are not known to interact with organic solvents such as ethanol. It was therefore all surprising that the swelling without heating in the selected organic solvents and that this change was detected even though the % of filler present in the polymer was small.

[0037] The extruded tubes were subjected to kink analysis. The kink analysis was performed to the standard EN13868. (Test methods for kinking of single lumen catheters and medical tubing - this standard specifies the test methods for the kink properties of single lumen catheters and medical tubing, as the kink properties are related to devices ready for clinical use. The purpose of this standard is to ensure uniformity in the evaluation of the kink properties of the tubes.) The corrected kink results are given in Figure 2 for a typical PVC tube as shown in the figure. Figure 3 shows a plot of the corrected kink distance in inches against the calculated wall thickness for several extruded medical tubes using the formulations in the table in Figure 1. Also shown in Figure 3 is a triangle for the kink distance value of a control thermoplastic material without fillers and coupling agents.

[0038] The results show that the tube design affects the corrected kink distance of the tube, but formulations having TPE along with fillers and coupling agents show similar corrected kink distance results as PVC.

[0039] For a tube dimension of 0.145" OD x 0.019" wall thickness (WT), we measure the kink resistance of the TPE to be 0.86"-0.97", while the competitive PVC tube results are 0.79"-0.93" (Figure 2). Figure 3 shows the effect of wall thickness, such that a TPE tube with a target wall thickness of 0.0190+ / -0.002" gives a kink resistance in the range of 0.89"-0.95", which is similar to the kink characteristics of the PVC tube formulation within measurement error.

[0040] The extruded tube was further subjected to electron beam irradiation, and preliminary results showed good electron beam irradiation stability of the extruded tube.

[0041] Identifying a thermoplastic material that can provide solvent adhesion comparable to PVC while at the same time providing kink resistance comparable to PVC is a significant challenge. The data shared in Figure 3 shows that the TPE formulations disclosed herein are comparable to PVC in terms of kink resistance properties within the expected measurement error of the test method. The swelling data showed that certain formulation attributes provide improved adhesion properties for the TPE when used compared to TPEs without such additives.

[0042] It is understood that any specific order or hierarchy of blocks in the disclosed process methods is illustrative of example approaches. Based on design or implementation preferences, it is understood that the specific order or hierarchy of blocks in the processes may be rearranged or all of the illustrated blocks may be performed. In some implementations, any of the blocks may be performed simultaneously.

[0043] This disclosure is provided to enable those skilled in the art to implement the various aspects described herein. This disclosure provides various examples of the technology, but the technology is not limited to these examples. Various modifications to these aspects will be readily apparent to those skilled in the art, and the general principles defined herein may be applied to other aspects.

[0044] Reference to a singular element does not mean "one and only one" unless specifically stated otherwise, but rather means "one or more." The term "several" refers to one or more, unless specifically stated otherwise. Masculine pronouns (e.g., his) include the feminine and neuter genders (e.g., her and its), and vice versa. Headings and subheadings, if any, are used for convenience only and are not intended to limit the invention.

[0045] The term "exemplary" is used herein to mean "serving as an example or illustration." Any aspect or design described herein as "exemplary" is not necessarily to be construed as preferred or advantageous over other aspects or designs. In one aspect, various alternative configurations and operations described herein can be considered at least equivalent.

[0046] As used herein, the phrase "at least one of" preceding a series of items, together with the term "or" separating any of the items, modifies the entire list and not each listed item. The phrase "at least one of" does not require the selection of at least one item. Instead, the phrase allows for the inclusion of at least one of any one of the items, and / or at least one of any combination of the items, and / or at least one of each of the items. By way of example, the phrase "at least one of A, B, or C" may refer to only A, only B, or only C, or to any combination of A, B, and C.

[0047] A phrase such as "aspect" does not mean that such aspect is essential to the technology or that such aspect applies to all configurations of the technology. A disclosure regarding an aspect may apply to all configurations or to one or more configurations. An aspect may provide one or more examples. A phrase such as an aspect may refer to one or more aspects, and vice versa. A phrase such as "embodiment" does not mean that such an embodiment is essential to the technology or that such an embodiment applies to all configurations of the technology. A disclosure regarding an embodiment may apply to all embodiments or to one or more embodiments. An embodiment may provide one or more examples. A phrase such as an embodiment may refer to one or more embodiments, and vice versa. A phrase such as "configuration" does not mean that such an embodiment is essential to the technology or that such an embodiment applies to all configurations of the technology. A disclosure regarding an embodiment may apply to all configurations or to one or more configurations. An embodiment may provide one or more examples. A phrase such as an embodiment may refer to one or more embodiments, and vice versa. A phrase such as "configuration" does not mean that such an embodiment is essential to the technology or that such an embodiment applies to all configurations of the technology. A disclosure regarding an embodiment may apply to all configurations or to one or more configurations. An embodiment may provide one or more examples. The term a composition may refer to one or more compositions, and vice versa.

[0048] In one aspect, unless otherwise stated, all measurements, values, ratings, locations, dimensions, sizes, and other specifications set forth in this specification, including the following claims, are approximate and not precise, and are intended to have a reasonable range consistent with the function to which they relate and with what is customary in the art to which they pertain.

[0049] It is understood that the specific order or hierarchy of steps, operations, or processes disclosed is an illustration of example approaches. It is understood that the specific order or hierarchy of steps, operations, or processes may be rearranged based on design preferences. Some of the steps, operations, or processes may be performed simultaneously. Some or all of the steps, operations, or processes may be performed automatically without user intervention. The accompanying method claims present various steps, operations, or process elements, if any, in a sample order, and are not intended to be limited to the specific order or hierarchy presented.

[0050] All structural and functional equivalents to the elements of the various embodiments described throughout this disclosure that are known or that later become known to those skilled in the art are intended to be expressly incorporated herein by reference and encompassed by the claims. Moreover, none of the content disclosed herein is intended to be made available to the public, regardless of whether such disclosure is expressly set forth in the claims. No element of a claim is to be construed under the provisions of 35 USC § 112(f) unless the element is expressly recited using the phrase "means for" or, in the case of a method claim, unless the element is recited using the phrase "step of." Moreover, to the extent that terms such as "include," "have," and the like are used, such terms are intended to be inclusive in the same manner as the term "comprise" would be interpreted if "comprise" were used as a transitional phrase in a claim.

[0051] The title, background, summary, brief description of the drawings, and abstract of this disclosure are incorporated into this disclosure and are provided as illustrative examples of this disclosure, not as limiting descriptions. They are submitted with the understanding that they will not be used to limit the scope or meaning of the claims. Furthermore, in the detailed description, it will be seen that the description provides illustrative examples, and that various features have been grouped together in various embodiments for the purpose of streamlining the disclosure. This method of disclosure should not be interpreted as reflecting an intention that the claimed subject matter requires more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive subject matter lies in less than all features of a single disclosed structure or operation. The following claims are incorporated into the detailed description, with each claim standing on its own as separately claimed subject matter.

[0052] The claims are not intended to be limited to the embodiments described herein, but are to be accorded the full scope consistent with the language of the claims, including all legal equivalents. Nonetheless, none of the claims are intended, and should not be construed, to cover subject matter that does not comply with the requirements of 35 USC §§ 101, 102, or 103.

Claims

1. A medical tube, comprising: another layer having a composition prepared from a melt blend of (i) a thermoplastic material, (ii) a non-silane reactive filler, and (iii) a thermally reactive coupling agent; A medical tubing having kink resistance comparable to medical tubing constructed of polyvinyl chloride having the same tube wall dimensions.

2. 10. The medical tubing of claim 1, wherein the layer is substantially free of polyvinyl chloride.

3. The medical tubing of claim 1 , wherein the thermoplastic material comprises one or more thermoplastic elastomers.

4. 10. The medical tubing of claim 1, wherein the thermoplastic material comprises from 1% to about 99% by weight of the medical tubing composition based on the total weight of the composition.

5. 10. The medical tubing of claim 1, wherein the filler comprises one or more of silica, glass beads, metal carbonates such as calcium carbonate, metal oxides, carbon black, mica, or nepheline syenite.

6. 10. The medical tubing of claim 1, wherein the filler comprises from 0.1% to about 5% by weight of the medical tubing composition based on the total weight of the composition.

7. 10. The medical tubing of claim 1, wherein the thermally reactive coupling agent comprises one or more of neopentyl(diallyl)oxy, tri(dioctyl)phosphato zirconate, neopentyl(diallyl)oxy, tri(dioctyl)phosphate titanate.

8. 10. The medical tubing of claim 1, wherein the thermally reactive coupling agent comprises from 0.5% to about 20% by weight of the medical tubing composition based on the total weight of the composition.

9. 10. The medical tubing of claim 1 having a wall thickness of about 0.01 to about 0.025 inches and a kink resistance in the range of about 0.70 inches to about 1.1 inches.

10. 10. The medical tubing of claim 1, which is capable of being solvent bonded.

11. 11. An infusion set comprising the medical tubing of claim 10 coupled to a medical connector.

12. The medical tubing of claim 1 comprising two or more lumens.

13. 10. The medical tubing of claim 1, which is a multi-layer tubing, at least one layer of which comprises the composition prepared from the melt blend.

14. A method for preparing the medical tube according to any one of claims 1, comprising the steps of: (i) combining a thermoplastic material, (ii) a filler, and (iii) a thermally reactive coupling agent with sufficient heat to form a melt blend composition; and extruding said molten blend composition into said medical tubing. A method comprising:

15. 15. The method of claim 14, wherein the thermoplastic material is substantially free of plasticizers or free of polyvinyl chloride.

16. The method of claim 14 , wherein the thermoplastic material comprises one or more thermoplastic elastomers.

17. 15. The method of claim 14, wherein the filler comprises one or more of silica, glass beads, metal carbonates such as calcium carbonate, metal oxides, carbon black, mica, or nepheline syenite.

18. The method of claim 14, wherein the filler comprises from 0.1% to about 5% by weight of the medical tubing composition based on the total weight of the composition.

19. 15. The method of claim 14, wherein the thermally reactive coupling agent comprises one or more of neopentyl(diallyl)oxy, tri(dioctyl)phosphato zirconate, neopentyl(diallyl)oxy, tri(dioctyl)phosphate titanate.

20. 15. The method of claim 14, wherein the thermally reactive coupling agent comprises from 0.5% to about 20% by weight of the medical tubing composition based on the total weight of the composition.

21. The method of claim 14, wherein the medical tubing has a wall thickness of about 0.01 to about 0.025 inches and a kink resistance in the range of about 0.70 inches to about 1.1 inches.

22. 15. The method of claim 14, further comprising forming a multi-layer medical tubing, wherein an inner layer comprising a polyolefin forms an inner layer and said melt blended composition forms an outer layer in said multi-layer medical tubing.